Sunshine Biopharma (SBFM) Net Margin Growth (3y) (2021 - 2026)
Sunshine Biopharma (SBFM) Net Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 1,620.00 |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -98.00 |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -4,358.00 |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -1,235.00 |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -100.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 4,252.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -404.00 |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | 1,941.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,941.00 |
| Dec 31, 2025 | 57,182.00 |
| Sep 30, 2025 | 110,023.00 |
| Jun 30, 2025 | 32,716.00 |
| Mar 31, 2025 | 99,472.00 |
| Dec 31, 2024 | -80,625.00 |
| Sep 30, 2024 | 800,427.00 |
| Jun 30, 2024 | 542,601.00 |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2022 | -609,247.00 |
| Jun 30, 2022 | -40,487.00 |
| Mar 31, 2022 | 1,727.00 |
| Mar 31, 2021 | -1.52 Mn |